PrIME Biologics' Series A Round

PrIME Biologics raised a round of funding on May 12, 2014.

PrIME Biologics (PrIME) is a Singapore based company that is building a plasma fractionation facility in Singapore to address the US$1b Asian Therapeutic Plasma products market.…

Articles about PrIME Biologics' Series A Round: